Fifth Third Bancorp’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4K | Sell |
|
|||||
|
2025
Q1 | $13.1K | Buy |
|
|||||
|
2024
Q4 | $9.32K | Sell |
|
|||||
|
2024
Q3 | $11.4K | Buy |
|
|||||
|
2024
Q2 | $9.18K | Buy |
|
|||||
|
2024
Q1 | $7.16K | Hold |
|
|||||
|
2023
Q4 | $7K | Sell |
|
|||||
|
2023
Q3 | $9.17K | Buy |
|
|||||
|
2023
Q2 | $9.23K | Buy |
|
|||||
|
2023
Q1 | $9.2K | Buy |
|
|||||
|
2022
Q4 | $4.88K | Buy |
|
|||||
|
2022
Q3 | $4K | Sell |
|
|||||
|
2022
Q2 | $6K | Buy |
|
|||||
|
2022
Q1 | $6K | Sell |
|
|||||
|
2021
Q4 | $759K | Buy |
|
|||||
|
2021
Q3 | $12K | Sell |
|
|||||
|
2021
Q2 | $31K | Sell |
|
|||||
|
2021
Q1 | $44K | Sell |
|
|||||
|
2020
Q4 | $55K | Sell |
|
|||||
|
2020
Q3 | $327K | Sell |
|
|||||
|
2020
Q2 | $522K | Buy |
|
|||||
|
2020
Q1 | $324K | Buy |
|
|||||
|
2019
Q4 | $423K | Sell |
|
|||||
|
2019
Q3 | $419K | Buy |
|
|||||
|
2019
Q2 | $414K | Buy |
|
|||||
|
2019
Q1 | $421K | Buy |
|
|||||
|
2018
Q4 | $433K | Buy |
|
|||||
|
2018
Q3 | $660K | Sell |
|
|||||
|
2018
Q2 | $630K | Sell |
|
|||||
|
2018
Q1 | $627K | Sell |
|
|||||
|
2017
Q4 | $659K | Buy |
|
|||||
|
2017
Q3 | $618K | Sell |
|
|||||
|
2017
Q2 | $619K | Buy |
|
|||||
|
2017
Q1 | $532K | Sell |
|
|||||
|
2016
Q4 | $554K | Sell |
|
|||||
|
2016
Q3 | $560K | Sell |
|
|||||
|
2016
Q2 | $677K | Sell |
|
|||||
|
2016
Q1 | $707K | Sell |
|
|||||
|
2015
Q4 | $716K | Sell |
|
|||||
|
2015
Q3 | $604K | Buy |
|
|||||
|
2015
Q2 | $644K | Sell |
|
|||||
|
2015
Q1 | $703K | Buy |
|
|||||
|
2014
Q4 | $434K | Buy |
|
|||||
|
2014
Q3 | $270K | Sell |
|
|||||
|
2014
Q2 | $377K | Buy |
|
|||||
|
2014
Q1 | $130K | Buy |
|